Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer (Q34987355)

5 August 2017

Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer (English)

1 reference

5 August 2017

1 reference

cervix uterine cancer

1 reference

Yao Yang

1

1 reference

5 August 2017

Kun-ling Song

series ordinal

2

1 reference

5 August 2017

Hong Chang

series ordinal

3

1 reference

5 August 2017

Long Chen

series ordinal

4

1 reference

5 August 2017

language of work or name

1 reference

31 December 2014

1 reference

5 August 2017

1 reference

5 August 2017

9

1 reference

5 August 2017

220

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13000-014-0220-x

0 references

cites work

MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

8 July 2018

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Comprehensive microRNA Profiling of Prostate Cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

MicroRNAs as potential biomarkers in human solid tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

MicroRNAs: molecular features and role in cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

A review of expression profiling of circulating microRNAs in men with prostate cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Clinical outcome prediction by microRNAs in human cancer: a systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (review).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

The microRNA pathway and cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

miR-126 functions as a tumour suppressor in human gastric cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

Endogenous human microRNAs that suppress breast cancer metastasis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4299682

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin− progenitor cells in ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13000-014-0220-X

miR-126 Suppresses the proliferation of cervical cancer cells and alters cell sensitivity to the chemotherapeutic drug bleomycin

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25551621

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Low expression of microRNA-126 is associated with poor prognosis in colorectal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25551621

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S13000-014-0220-X

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference